... bowel syndrome Fecal microbiota transplantation Functional diarrhea Prevotella Short-chain fatty acids Patients with functional gastrointestinal disorders (FGIDs) typically present with chronic recurrent abdominal symptoms despite the absence of organ abnormalities. Functional bowel...

... or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. 2022 Short-chain fatty acids Butyrate Mycobiome Virome...

..., metabolism, infection, nervous system, social behaviors, and psychopathology, etc., maybe via modulating gut barrier, microbiome-gut-brain axis, or some metabolites like short-chain fatty acids (SCFAs). Summary: In the review, we will conclude the recent researches related to the influence of microbiome...

... scoring system (IBS-SSS). Short-chain fatty acids (SCFAs) were analyzed in fecal samples before and after the dietary intervention, both at baseline and after in vitro fermentation for 24 h. Results: Sixty-three patients completed the study. Following the dietary intervention, IBS-SSS scores improved...

... to short-chain fatty acids (SCFAs; acetate, propionate and butyrate), collaborating with species specialized in oligosaccharide fermentation (e.g. Bifidobacteria ). Butyrate and propionate can regulate intestinal physiology and immune function, while acetate acts as a substrate for lipogenesis...

... to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. 2016 Short-chain fatty acids Microbiota Firmicutes Inflammatory bowel diseases (IBDs), including ulcerative colitis and Crohn's disease (CD), are chronic...

... if these effects were influenced by short-chain fatty acids (SCFA). Both CT and ST induced similar changes in water and electrolyte fluxes, and the magnitude of these changes in loops of colon was similar to that observed in loops of ileum. The addition of luminal SCFA, acetate, propionate and butyrate did...

... by clindamycin exposure alone (312.5 mg/day for 5 days) or by a combined treatment of clindamycin and S. boulardii (400 mg/day for 5 days). Results: Clindamycin resulted in significant decreases in production rates of short-chain fatty acids (SCFAs) which were associated with substantial changes in molar SCFA...